Oruka Therapeutics, Inc. ORKA Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s interest income?
- Oruka Therapeutics, Inc. (ORKA) reported interest income of $4.61M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s interest income changed year-over-year?
- Oruka Therapeutics, Inc.'s interest income increased by 12.6% year-over-year, from $4.09M to $4.61M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Oruka Therapeutics, Inc.'s interest income has grown at a 498.0% compound annual growth rate (CAGR), from $13K to $16.63M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.